Potential Action of IL-4 and IL-13 as Fibrogenic Factors on Lung Fibroblasts in vitro
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Background: Asthma is characterized by chronic inflammation of the airway with the presence of Th2 cytokines. Airway remodeling in asthma is closely related to clinical manifestations. Lung myofibroblasts play a critical role in the airway remodeling and Th2 cytokines may modulate their behavior. We examined the effect of two major Th2 cytokines, IL-4 and IL-13, on differentiation of lung fibroblasts to myofibroblasts. We hypothesized that these cytokines would stimulate fibroblast proliferation in association with decreased prostaglandin E 2 (PGE 2). Methods: Lung fibroblasts were incubated with IL-4 and IL-13 with or without Th1 cytokine interferon-γ (IFN-γ) in vitro. Differentiation of lung fibroblasts to myofibroblasts was characterized by the expression of α-smooth muscle actin (α-SMA) as well as a morphological and immunohistochemical analysis. Fibroblast proliferation stimulated by IL-4 and IL-13 was assessed with the MTT assay. We also investigated the effect of these cytokines on cyclooxygenase (COX) gene expression and PGE 2 production. Results: IL-4 and IL-13 increased α-SMA expression and myofibroblastic differentiation. This effect was attenuated by IFN-γ and dexamethasone failed to have an influence on differentiation. IL-4 and IL-13 stimulated fibroblast proliferation. These cytokines downregulated the expression of both COX-1 and COX-2 genes and decreased the production of PGE 2. Conclusions: IL-4 and IL-13 induce differentiation of fibroblasts to myofibroblasts and this response is attenuated by IFN-γ. IL-4 and IL-13 stimulate fibroblast proliferation and this effect is at least partly due to suppressed COX gene expressions and subsequently decreased PGE 2 production. These findings suggest that IL-4 and IL-13 directly act on lung fibroblast to induce a fibrogenic response.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies that focused on the Th2 cytokines IL-4 and IL-13 showed them to stimulate fibroblast proliferation, collagen production, and fibroblast to myofibroblast differentiation—thereby rendering Th2 cells fibrogenic (137).”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [137]
In the citing paper
“detection of Th2 cells and their secretory mediators appears to be enhanced in the lungs and blood of patients with IPF (137–140).”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [137]
In the citing paper
“Both cytokines induce αSMA expression in primary lung fibroblasts in a dose- and time-dependent manner (105, 150), and enhance the production of collagen type I in normal fibroblasts (108).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [105]
Citations
Cites
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617
Desmoulière, A., Geinoz, A., Gabbiani, F., & Gabbiani, G. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.103 · Cited by 2,243
Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2
Smith, W. L., Garavito, R. M., & DeWitt, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33157 · Cited by 1,978
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719
Disruption of the murine IL-4 gene blocks Th2 cytokine responses
Kopf, M., Gros, G. L., Bachmann, M., Lamers, M. C., Bluethmann, H., & Köhler, G. (1993) · Nature · doi:10.1038/362245a0 · Cited by 1,203
IMMUNOLOGIC BASIS OF ANTIGEN-INDUCED AIRWAY HYPERRESPONSIVENESS
Wills-Karp, M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.255 · Cited by 1,020
Del Prete, G., Maggi, E., Parronchi, P., Chrétien, I., Tiri, A., Macchia, D., Ricci, M., Banchereau, J., De Vries, J., & Romagnani, S. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.12.4193 · Cited by 707
Myofibroblasts and Subepithelial Fibrosis in Bronchial Asthma
Brewster, C. E. P., Howarth, P. H., Djukanovic, R., Wilson, J., Holgate, S. T., & Roche, W. R. (1990) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/3.5.507 · Cited by 663
Research works printed but not linked: 1
- 10.1146/annurev.immunol.7.1.145 · doi:10.1146/annurev.immunol.7.1.145 · Paper page
Cited by
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
Pulmonary fibrosis: pathogenesis, etiology and regulation
Wilson, M. S., & Wynn, T. A. (2009) · Mucosal Immunology · doi:10.1038/mi.2008.85 · Cited by 822
TGF-β1 Signaling and Tissue Fibrosis
Kim, K. K., Sheppard, D., & Chapman, H. A. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022293 · Cited by 800
“Earlier studies exploring the response of airway fibroblasts to IL-4 report similar findings, suggesting that in some way the ongoing inflammation and stimulation of stromal elements primes these airway fibroblasts for further response (Saito et al. 2003).”
ResultInflammation and immunity in IPF pathogenesis and treatment
Heukels, P., Moor, C. C., von der Thüsen, J. H., Wijsenbeek, M. S., & Kool, M. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2018.12.015 · Cited by 517
Oku, H., Shimizu, T., Kawabata, T., Nagira, M., Hikita, I., Ueyama, A., Matsushima, S., Torii, M., & Arimura, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.046 · Cited by 436
Cytokine mediated tissue fibrosis
Borthwick, L. A., Wynn, T. A., & Fisher, A. J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.014 · Cited by 375
Immune mechanisms in pulmonary fibrosis
Kolahian, S., Fernandez, I. E., Eickelberg, O., & Hartl, D. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0121tr · Cited by 349
The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Desai, O., Winkler, J., Minasyan, M., & Herzog, E. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00043 · Cited by 314
Immune dysregulation as a driver of idiopathic pulmonary fibrosis
Shenderov, K., Collins, S. L., Powell, J. D., & Horton, M. R. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143226 · Cited by 295
D'Urso, M., & Kurniawan, N. A. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.609653 · Cited by 280
Role of interleukins in the pathogenesis of pulmonary fibrosis
She, Y. X., Yu, Q. Y., & Tang, X. X. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00437-9 · Cited by 219
From Seminars in Respiratory and Critical Care Medicine
Spurzem, J. R., & Rennard, S. I. (2011) · Cited by 214
Regulation of extracellular matrix assembly and structure by hybrid M1/M2 macrophages
Witherel, C. E., Sao, K., Brisson, B. K., Han, B., Volk, S. W., Petrie, R. J., Han, L., & Spiller, K. L. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120667 · Cited by 212
Novel therapeutic approaches for pulmonary fibrosis
Datta, A., Scotton, C. J., & Chambers, R. C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01247.x · Cited by 202
Yang, G., Volk, A., Petley, T., Emmell, E., Giles-Komar, J., Shang, X., Li, J., Das, A. M., Shealy, D., Griswold, D. E., et al. (2004) · Cytokine · doi:10.1016/j.cyto.2004.08.007 · Cited by 192
The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling
Doherty, T. A., Soroosh, P., Khorram, N., Fukuyama, S., Rosenthal, P., Cho, J. Y., Norris, P. S., Choi, H., Scheu, S., Pfeffer, K., et al. (2011) · Nature Medicine · doi:10.1038/nm.2356 · Cited by 171
Fibroblast-to-myofibroblast transition in bronchial asthma
Michalik, M., Wójcik‐Pszczoła, K., Paw, M., Wnuk, D., Koczurkiewicz, P., Sanak, M., Pękala, E., & Madeja, Z. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2899-4 · Cited by 181
Unraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
“Both cytokines induce αSMA expression in primary lung fibroblasts in a dose- and time-dependent manner (105, 150), and enhance the production of collagen type I in normal fibroblasts (108).”
BackgroundHyper-responsiveness of IPF/UIP fibroblasts: Interplay between TGFβ1, IL-13 and CCL2
Murray, L. A., Argentieri, R. L., Farrell, F. X., Bracht, M., Sheng, H., Whitaker, B., Beck, H., Tsui, P., Cochlin, K., Evanoff, H. L., et al. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.02.016 · Cited by 175
Dysregulation of metabolic pathways in pulmonary fibrosis
Rajesh, R., Atallah, R., & Bärnthaler, T. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108436 · Cited by 139
Barbarin, V., Xing, Z., Delos, M., Lison, D., & Huaux, F. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00329.2004 · Cited by 122
Ayaub, E. A., Dubey, A., Imani, J., Botelho, F., Kolb, M. R. J., Richards, C. D., & Ask, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-13511-z · Cited by 120
Gabryelska, A., Kuna, P., Antczak, A. J., Białasiewicz, P., & Panek, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00692 · Cited by 135
Polymorphisms Associated with Asthma Are Inversely Related to Glioblastoma Multiforme
Schwartzbaum, J., Ahlbom, A., Malmer, B., Lönn, S., Brookes, A. J., Doss, H., Debinski, W., Henriksson, R., & Feychting, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3728 · Cited by 121
Peripheral blood biomarkers in idiopathic pulmonary fibrosis
Vij, R., & Noth, I. (2012) · Translational Research · doi:10.1016/j.trsl.2012.01.012 · Cited by 117
Myofibroblasts and lung fibrosis induced by carbon nanotube exposure
Dong, J., & Ma, Q. (2016) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0172-2 · Cited by 119
Transcription Factors T-bet and GATA-3 Regulate Development of Airway Remodeling
Kiwamoto, T., Ishii, Y., Morishima, Y., Yoh, K., Maeda, A., Ishizaki, K., Iizuka, T., Hegab, A. E., Matsuno, Y., Homma, S., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200601-079oc · Cited by 119
CD4+ T Lymphocytes, Especially Th2 Cells, Contribute to the Progress of Renal Fibrosis
Liu, L., Kou, P., Zeng, Q., Pei, G., Li, Y., Liang, H., Xu, G., & Chen, S. (2012) · American Journal of Nephrology · doi:10.1159/000343283 · Cited by 111
Polymorphisms Associated with Asthma Are Inversely Related to Glioblastoma Multiforme
Blakely, J. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3200 · Cited by 108
Are mast cells instrumental for fibrotic diseases?
Overed-Sayer, C., Rapley, L., Mustelin, T., & Clarke, D. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00174 · Cited by 105
The Role of an IL-10/Hyaluronan Axis in Dermal Wound Healing
Singampalli, K. L., Balaji, S., Wang, X., Parikh, U. M., Kaul, A., Gilley, J., Birla, R. K., Bollyky, P. L., & Keswani, S. G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00636 · Cited by 125
Therapeutic Dosing with Anti-Interleukin-13 Monoclonal Antibody Inhibits Asthma Progression in Mice
Yang, G., Li, L., Volk, A. P. D., Emmell, E., Petley, T., Giles-Komar, J. M., Rafferty, P., Lakshminarayanan, M. Y., Griswold, D. E., Bugelski, P. J., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076133 · Cited by 90
Regulation of Fibrosis by the Immune System
Lupher, M., & Gallatin, W. M. (2006) · Advances in immunology · doi:10.1016/s0065-2776(05)89006-6 · Cited by 101
Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis
Huang, X., Wang, Y., Yan, J., Wan, Y.-N., Chen, B., Li, B., Yang, G., & Wang, J. (2015) · Inflammation Research · doi:10.1007/s00011-015-0806-0 · Cited by 83
Yamaji-Kegan, K., Su, Q., Angelini, D. J., Myers, A. C., Cheadle, C., & Johns, R. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904021 · Cited by 82
Targeting IL-13 and IL-4 in Asthma: Therapeutic Implications on Airway Remodeling in Severe Asthma
Sahnoon, L., Bajbouj, K., Mahboub, B., Hamoudi, R., & Hamid, Q. A. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09045-2 · Cited by 103
Mast cells in airway diseases and interstitial lung disease
Cruse, G., & Bradding, P. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.04.046 · Cited by 79
T cells in idiopathic pulmonary fibrosis: crucial but controversial
Deng, L., Huang, T., & Zhang, L. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01344-x · Cited by 74
Liu, Y., Zha, W., Ma, Y., Chen, F.-F., Zhu, W., Ge, A., Zeng, X., & Huang, M. (2015) · Scientific Reports · doi:10.1038/srep11758 · Cited by 76
Ma, Y., Zhang, J., Liu, Y., Ge, A., Gu, H., Zha, W., Zeng, X., & Huang, M. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.09.012 · Cited by 71
Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis
Hams, E., Bermingham, R., & Fallon, P. G. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00597 · Cited by 75
Adenosine metabolism and murine strain-specific IL-4-induced inflammation, emphysema, and fibrosis
Ma, B., Blackburn, M. R., Lee, C. G., Homer, R. J., Liu, W., Flavell, R. A., Boyden, L., Lifton, R. P., Sun, C.-X., Young, H. W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26372 · Cited by 72
Sokolova, E., & Reiser, G. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.04.002 · Cited by 65
The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma
Min, C. (2011) · The Korean Journal of Hematology · doi:10.5045/kjh.2011.46.2.80 · Cited by 61
Antunes, R. D. S., Mehta, A. K., Madge, L. A., Tocker, J. E., & Croft, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00576 · Cited by 64
Checa, J., & Aran, J. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239317 · Cited by 61
Sex Hormones and Lung Inflammation
Reyes-García, J., Montaño, L. M., Carbajal-García, A., & Wang, Y.-X. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-68748-9_15 · Cited by 65
Overexpression of the transcription factor GATA-3 enhances the development of pulmonary fibrosis
Kimura, T., Ishii, Y., Yoh, K., Morishima, Y., Iizuka, T., Kiwamoto, T., Matsuno, Y., Homma, S., Nomura, A., Sakamoto, T., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051160 · Cited by 55
Interactions Between Tissue Fibroblasts in Lymph Nodes and Hodgkin/Reed-Sternberg Cells
Aldinucci, D., Lorenzon, D., Olivo, K., Rapanà, B., & Gattei, V. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190410001683633 · Cited by 61
Roach, K. M., & Bradding, P. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14939 · Cited by 67
Anoxia-Reoxygenation Stimulates Collagen Type-I and MMP-1 Expression in Cardiac Fibroblasts
Chen, K., Li, D., Zhang, X., Hermonat, P. L., & Mehta, J. L. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200412000-00010 · Cited by 54
Regulation of T helper cell subsets by cyclooxygenases and their metabolites
Li, H., Edin, M. L., Gruzdev, A., Cheng, J., Bradbury, J. A., Graves, J. P., DeGraff, L. M., & Zeldin, D. C. (2012) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.11.002 · Cited by 59
Saw, V. P. J., Offiah, I., Dart, R., GALATOWICZ, G. E., Dart, J. K. G., Daniels, J. T., & Calder, V. L. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090579 · Cited by 53
Drug delivery strategies to control macrophages for tissue repair and regeneration
Garash, R., Bajpai, A., Marcinkiewicz, B. M., & Spiller, K. L. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216649444 · Cited by 50
Microarray identifies ADAM family members as key responders to TGF-β1 in alveolar epithelial cells
Keating, D., Sadlier, D. M., Patricelli, A., Smith, S. M., Walls, D., Egan, J. J., & Doran, P. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-114 · Cited by 60
Kass, D. J., Yu, G., Loh, K. S., Savir, A., Borczuk, A., Kahloon, R., Juan-Guardela, B., Deiuliis, G., Tedrow, J., Choi, J., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.01.010 · Cited by 51
Differentiation Potential of CD14+ Monocytes into Myofibroblasts in Patients with Systemic Sclerosis
Binai, N. A., O’Reilly, S., Griffiths, B., van Laar, J. M., & Hügle, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033508 · Cited by 57
Fattouh, R., & Jordana, M. (2008) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152808786848388 · Cited by 48
Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis
Jangra, A., Kothari, A., Sarma, P., Medhi, B., Omar, B. J., & Kaushal, K. (2022) · Cells · doi:10.3390/cells11091500 · Cited by 58
Spagnolo, P., Tonelli, R., Samarelli, A. V., Castelli, G., Cocconcelli, E., Petrarulo, S., Cerri, S., Bernardinello, N., Clini, E. M., Saetta, M. P., et al. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2114897 · Cited by 45
Otaki, N., Motomura, Y., Terooatea, T. W., Kelly, S. T., Mochizuki, M., Takeno, N., Koyasu, S., Tamamitsu, M., Sugihara, F., Kikuta, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43336-6 · Cited by 52
Th2-Biased Immune Responses Are Important in a Murine Model of Chronic Hypersensitivity Pneumonitis
Mitaka, K., Miyazaki, Y., Yasui, M., Furuie, M., Miyake, S., Inase, N., & Yoshizawa, Y. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000321114 · Cited by 55
Obligatory Role for Interleukin-13 in Obstructive Lesion Development in Airway Allografts
Lama, V. N., Harada, H., Badri, L. N., Flint, A., Hogaboam, C. M., McKenzie, A. N. J., Martínez, F. J., Toews, G. B., Moore, B. B., & Pinsky, D. J. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050975 · Cited by 44
Adegunsoye, A., Hrusch, C. L., Bonham, C. A., Jaffrey, M. R., Blaine, K. M., Sullivan, M., Churpek, M. M., Strek, M. E., Noth, I., & Sperling, A. I. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00516 · Cited by 48
Kimura, T., Ishii, Y., Morishima, Y., Shibuya, A., Shibuya, K., Taniguchi, M., Mochizuki, M., Hegab, A. E., Sakamoto, T., Nomura, A., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5782 · Cited by 43
Russo, R. L., Cozzani, E., Gasparini, G., & Parodi, A. (2019) · Dermatologic Therapy · doi:10.1111/dth.13190 · Cited by 42
Central Nervous System Fibrosis Is Associated with Fibrocyte-Like Infiltrates
Aldrich, A. L., & Kielian, T. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.08.036 · Cited by 44
Sustained Suppression of IL-13 by a Vaccine Attenuates Airway Inflammation and Remodeling in Mice
Ma, Y., Halayko, A. J., Basu, S., Guan, Q., Weiss, C. R., Ma, A. G., HayGlass, K. T., Becker, A. B., Warrington, R., & Peng, Z. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0060oc · Cited by 39
Targeted anti-IL-13 therapies in asthma: current data and future perspectives
Ntontsi, P., Papathanassiou, E., Loukides, S., Bakakos, P., & Hillas, G. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1427729 · Cited by 41
Molecular determinants of mesenchymal cell activation in fibroproliferative diseases
Penke, L. R. K., & Peters-Golden, M. L. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03212-3 · Cited by 43
Chang, C., Lin, C., Lee, C., Chuang, H., Shih, F.-C., Wan, S.-W., Tai, C., & Chen, C. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114356 · Cited by 46
IL-4 Is Proangiogenic in the Lung under Hypoxic Conditions
Yamaji-Kegan, K., Su, Q., Angelini, D. J., & Johns, R. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0713347 · Cited by 41
Role of Mesenchymal Stem Cells and Extracellular Vesicles in Idiopathic Pulmonary Fibrosis
Kletukhina, S. K., Mutallapova, G., Андреевна, Т. А., & Gomzikova, M. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911212 · Cited by 40
Borowski, A., Kuepper, M., Horn, U., Knüpfer, U., Zissel, G., Höhne, K., Luttmann, W., Krause, S., Virchow, J. C., & Friedrich, K. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.02944.x · Cited by 38
Cyclosporine A Drives a Th17- and Th2-Mediated Posttransplant Obliterative Airway Disease
Lemaitre, P. H., Vokaer, B., Charbonnier, L., Iwakura, Y., Field, K. A., Estenne, M., Goldman, M., Léo, O., Remmelink, M., & Moine, A. L. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12067 · Cited by 37
Warsinske, H., Wheaton, A. K., Kim, K. K., Linderman, J. J., Moore, B. B., & Kirschner, D. E. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00183 · Cited by 38
Muscle regeneration, inflammation, and connective tissue expansion in canine inflammatory myopathy
Salvadori, C., Peters, I. R., Day, M. J., Engvall, E., & Shelton, G. D. (2004) · Muscle & Nerve · doi:10.1002/mus.20252 · Cited by 35
Lu, W., Teoh, A. K. Y., Waters, M., Haug, G., Shakeel, I., Hassan, M. I., Shahzad, A. M., Larsson‐Callerfelt, A., Piccari, L., & Sohal, S. S. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108757 · Cited by 37
The role of interleukin-33 in organ fibrosis
Carmine, S. D., Scott, M. M., McLean, M. H., & McSorley, H. J. (2022) · Discovery Immunology · doi:10.1093/discim/kyac006 · Cited by 34
IL-13 Induces YY1 through the AKT Pathway in Lung Fibroblasts
Guo, J., Yao, H., Lin, X., Xu, H., Dean, D. A., Zhu, Z., Liu, G., & Sime, P. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119039 · Cited by 31
Is personalised medicine the key to heterogeneity in idiopathic pulmonary fibrosis?
Clarke, D. L., Murray, L. A., Crestani, B., & Sleeman, M. A. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.09.010 · Cited by 32
Deleterious Role of Th9 Cells in Pulmonary Fibrosis
Deng, K., Yang, X. S., Luo, Q., She, Y. X., Yu, Q. Y., & Tang, X. X. (2021) · Cells · doi:10.3390/cells10113209 · Cited by 35
Rectenwald, J. E., Deatrick, K. B., Sukheepod, P., Lynch, E. M., Moore, A. J., Moaveni, D. M., Deywer, N. A., Luke, C. E., Upchurch, G. R., Wakefield, T. W., et al. (2006) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2005.12.010 · Cited by 29
Ingram, J. L., Slade, D., Church, T. D., Francisco, D., Heck, K., Sigmon, R. W., Ghio, M., Murillo, A., Firszt, R., Lugogo, N. L., et al. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0290oc · Cited by 29
Wang, Q., Xie, Z., Wu, Q., Jin, Z., Yang, C., & Feng, J. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001288 · Cited by 30
The Effect of Nintedanib on T-Cell Activation, Subsets and Functions
Ubieta, K., Thomas, M. J., & Wollin, L. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s288369 · Cited by 31
Rahman, M., Irmler, M., Keshavan, S., Introna, M., Beckers, J., Palmberg, L., Johanson, G., Ganguly, K., & Upadhyay, S. (2021) · Viruses · doi:10.3390/v13122537 · Cited by 26
Emerging therapeutic interventions for idiopathic pulmonary fibrosis
Chakraborty, S., Chopra, P., Ambi, S. V., Dastidar, S. G., & Ray, A. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.913569 · Cited by 29
Filho, H. O. S., Morandini, A. C., Ramos‐Junior, E. S., Jimbo, R., Santos, C. F., Marcantônio, É., Wennerberg, A., & Marcantonio, R. A. C. (2012) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34200 · Cited by 27
Misson, P., Brombacher, F., Delos, M., Lison, D., & Huaux, F. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00503.2005 · Cited by 24
Elnaggar, R., Hanawa, H., Liu, H., Yoshida, T., Hayashi, M., Watanabe, R., Abe, S., Toba, K., Yoshida, K., Chang, H., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200425776 · Cited by 24
CISH is a negative regulator of IL-13-induced CCL26 production in lung fibroblasts
Takeshima, H., Horie, M., Mikami, Y., Makita, K., Miyashita, N., Matsuzaki, H., Noguchi, S. F., Urushiyama, H., Hiraishi, Y., Mitani, A., et al. (2018) · Allergology International · doi:10.1016/j.alit.2018.08.005 · Cited by 20
A Novel Fibroblast Reporter Cell Line for in vitro Studies of Pulmonary Fibrosis
Németh, J., Schundner, A., Quast, K., Winkelmann, V. E., & Frick, M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.567675 · Cited by 21
Cytokines associated with toxicity in the treatment of recurrent glioblastoma with aflibercept
Shonka, N., Piao, Y., Gilbert, M. R., Yung, A. W. K., Chang, S. M., DeAngelis, L. M., Lassman, A. B., Liu, J., Cloughesy, T. F., Robins, H. I., et al. (2013) · Targeted Oncology · doi:10.1007/s11523-013-0254-0 · Cited by 18
Wang, X. Q., Mao, L., Fang, Q., Kobayashi, T., Kim, H. J., Sugiura, H., Kawasaki, S., Togo, S., Kamio, K., Liu, X., et al. (2014) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2014.02.002 · Cited by 18
Chronic features of allergic asthma are enhanced in the absence of resistin-like molecule-beta
LeMessurier, K. S., Palipane, M., Tiwary, M., Gavin, B. P., & Samarasinghe, A. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-25321-y · Cited by 18
Novel Strategies for the Treatment of Asthma
Takizawa, H. (2007) · Recent Patents on Inflammation & Allergy Drug Discovery · doi:10.2174/187221307779815101 · Cited by 17
Self-citationModulation of lung inflammation by the Epstein-Barr virus protein Zta
Guenther, J. F., Cameron, J. E., Hồng, N. T., Wang, Y., Sullivan, D. E., Shan, B., Lasky, J. A., Flemington, E. K., & Morris, G. F. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00408.2009 · Cited by 16
CCL2 and T cells in pulmonary fibrosis: an old player gets a new role
Osafo-Addo, A. D., & Herzog, E. L. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210517 · Cited by 18
Is there a role for specialized pro-resolving mediators in pulmonary fibrosis?
Thatcher, T. H., Freeberg, M. A. T., Myo, Y. P. A., & Sime, P. J. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108460 · Cited by 15
Metadata
- Authors
- Saito, A., Okazaki, H., Sugawara, I., Yamamoto, K., & Takizawa, H.
- Affiliations
- The University of Tokyo (JP)
- Venue
- International Archives of Allergy and Immunology
- Publisher
- S. Karger AG
- Published
- 2003
- Volume
- 132
- Issue
- 2
- Pages
- 168-176
- ISSN
- 1018-2438 (ISSN-L)
- 1423-0097
- OpenAlex
- W1981901332
- Cited by
- 167
- References
- 36
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 7 · 2023: 10 · 2022: 12 · 2021: 12 · 2020: 7 · 2019: 6 · 2018: 9 · 2017: 3 · 2016: 11 · 2015: 8 · 2014: 3 · 2013: 3 · 2012: 10
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- International Archives of Allergy and Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- IL-4, IL-13, lung fibroblasts, myofibroblast differentiation, airway remodeling, asthma, Th2 cytokines, interferon-gamma, prostaglandin E2, cyclooxygenase, alpha-smooth muscle actin, fibroblast proliferation, fibrogenesis
- MeSH terms
- Actins, Cell Differentiation, Cell Division, Cells, Cultured, Fibroblasts, Fibrosis, Humans, Immunohistochemistry, Indomethacin, Interferon-gamma, Isoenzymes, Lung, Membrane Proteins, Prostaglandin-Endoperoxide Synthases, RNA, Dinoprostone, Interleukin-4, Transforming Growth Factor beta, Interleukin-13, Reverse Transcriptase Polymerase Chain Reaction, Cyclooxygenase 1, Cyclooxygenase 2, Transforming Growth Factor beta1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.